TIGIT: A Breakthrough Target to Combat Tumor Immunotherapy Resistance
Malignant tumors continue to pose one of the most formidable challenges in modern medicine, persistently eluding the full efficacy of ...
Malignant tumors continue to pose one of the most formidable challenges in modern medicine, persistently eluding the full efficacy of ...
In a groundbreaking study emerging from the University of South Florida, researchers have delved deep into the intersection of artificial ...
SAN DIEGO, APRIL 13, 2026 — Dr. Jennifer Wargo, a leading physician-scientist and professor at The University of Texas MD ...
In a groundbreaking advancement poised to redefine the landscape of immunotherapy, researchers have unveiled a novel strategy employing allogeneic CD19 ...
In a groundbreaking study poised to redefine longstanding principles in immunology, Dr. Pavan Reddy and his team at the Dan ...
For decades, Chimeric Antigen Receptor T-cell (CAR-T) therapy has stood as a beacon of hope in oncology, especially in the ...
In a groundbreaking advancement that could redefine the future of cancer immunotherapy, researchers have engineered an innovative in vivo “charging ...
In a groundbreaking study that promises to reshape the landscape of cancer immunotherapy, researchers have unveiled a novel bispecific molecule ...
In the evolving landscape of cancer immunotherapy, CD4+ T cells are rapidly emerging from the shadow of their more famous ...
A groundbreaking study recently published in Mechanobiology in Medicine has unveiled a revolutionary function of T cells, transforming our understanding ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine